Neurology

18 source-linked study cards in this body system.

Gabapentin
Clonazepam
Sumatriptan
Lamotrigine
Topiramate
Pregabalin
Meclizine
Donepezil
Levetiracetam
Memantine
Rizatriptan
Ropinirole
Divalproex Sodium
Pramipexole
Carbamazepine
RimegepantNurtec
PrimidoneMysoline
Oxcarbazepine

Drug classes in this body system

How each medicine works

Medicines in this body system: 18 · in a drug class: 5 · drug classes: 3

Gabapentin — The exact analgesic and antiepileptic mechanisms are unknown. Gabapentin is structurally related to GABA but does not affect its binding, uptake or degradation. It binds the alpha-2-delta calcium-channel subunit in vitro; the relevance to therapeutic effects is unknown.
Clonazepam — Precise mechanism unknown; believed to enhance activity of GABA, the major inhibitory CNS neurotransmitter.
Sumatriptan — Presumed to act in migraine through 5-HT1B/1D agonism on intracranial vessels and trigeminal sensory nerves, producing cranial vasoconstriction and reduced pro-inflammatory neuropeptide release.
Lamotrigine — Precise mechanism unknown; proposed inhibition of voltage-sensitive sodium channels, stabilizing membranes and reducing glutamate release.
Topiramate — Clinical anticonvulsant and migraine-prevention mechanisms are unknown. Preclinical findings suggest contributions from sodium-channel blockade, enhanced activity at some GABA-A receptors, AMPA/kainate antagonism and carbonic-anhydrase inhibition.
Pregabalin — Binds with high affinity to the alpha-2-delta subunit of voltage-gated calcium channels in CNS tissue; exact mechanism not fully known.
Meclizine — Precise mechanism unknown; presumed to involve histamine H1 receptor antagonism.
Donepezil — Reversibly inhibits acetylcholinesterase, increasing acetylcholine and enhancing cholinergic function.
Levetiracetam — The precise antiepileptic mechanism is unknown. Experimental data identify a binding site as synaptic vesicle protein SV2A, thought to regulate vesicle exocytosis; interaction with SV2A may contribute to the antiepileptic effect.
Memantine — A low-to-moderate-affinity uncompetitive (open-channel) NMDA receptor antagonist. Its therapeutic effect is postulated to relate to blocking NMDA channels; persistent glutamate activation is a hypothesis in Alzheimer symptoms, and memantine has not been shown to prevent or slow neurodegeneration.
Rizatriptan — Presumed to treat migraine by binding 5-HT1B/1D receptors on intracranial blood vessels and sensory nerves of the trigeminal system.
Ropinirole — Non-ergoline dopamine agonist thought to act by stimulating D2 receptors in the caudate-putamen.
Divalproex Sodium — Dissociates to valproate; mechanism not established, possibly increased brain GABA concentrations.
Pramipexole — Non-ergot dopamine agonist with in-vitro activity at D2-family receptors and greater affinity for D3 than D2 or D4. The precise mechanisms in Parkinson disease and restless legs syndrome are unknown.
Carbamazepine — Animal studies suggest reduced polysynaptic responses and blocked post-tetanic potentiation; the mechanism of action remains unknown.
Rimegepant — Calcitonin gene-related peptide (CGRP) receptor antagonist.
Primidone — Antiepileptic mechanism unknown; primidone and its metabolites phenobarbital and PEMA all have anticonvulsant activity.
Oxcarbazepine — Activity is mainly mediated by MHD. The precise anti-seizure mechanism is unknown; in-vitro studies indicate voltage-sensitive sodium-channel blockade that stabilizes hyperexcited membranes.

Each summary is the mechanism line from the medicine’s study card.

Listed most often on cards in this body system

Common side effects

Dizziness · 11/18: Gabapentin, Lamotrigine, Topiramate, Pregabalin, Levetiracetam, Memantine, Rizatriptan, Ropinirole, Pramipexole, Carbamazepine (+1)

Nausea · 9/18: Lamotrigine, Donepezil, Ropinirole, Divalproex Sodium, Pramipexole, Carbamazepine, Rimegepant, Primidone, Oxcarbazepine

Somnolence · 8/18: Gabapentin, Pregabalin, Levetiracetam, Rizatriptan, Ropinirole, Divalproex Sodium, Pramipexole, Oxcarbazepine

Ataxia · 4/18: Gabapentin, Clonazepam, Lamotrigine, Primidone

Fatigue · 4/18: Gabapentin, Topiramate, Meclizine, Oxcarbazepine

Drowsiness · 4/18: Clonazepam, Meclizine, Carbamazepine, Primidone

Headache · 3/18: Lamotrigine, Meclizine, Memantine

Diplopia · 3/18: Lamotrigine, Primidone, Oxcarbazepine

Boxed warning

4/18: Clonazepam, Lamotrigine, Divalproex Sodium, Carbamazepine

An item counts as shared only when both cards use the same wording. If a card does not list an item, that is not a statement that the effect never occurs.